Heart failure is a serious issue in Latin America and the Caribbean, often leading to poor health and a lower quality of life. Once diagnosed, patients face a tough journey of rehabilitation and adopting healthier habits. However, sticking to treatment plans is easier said than done. Technology is stepping up to bridge this gap. It's making it easier for patients to...
Chronic myeloid leukemia (CML) patients face a tough question after hitting remission: what's next? Doctors often lack clear guidelines for managing care at this stage. A recent study tackles this issue by creating a model to predict the risk of relapse. The model focuses on early changes in BCR::ABL1 biomarker levels and how well patients stick to their treatment pl...
High blood pressure is a big deal. It's a major cause of heart problems and strokes. Many people struggle to stick to their treatment plans, which is a real issue. There are ways to make it easier for people to follow their treatment. One effective method is using fixed-dose combinations. These are pills that mix several medicines into one. This approach can make a b...
The bond between a doctor and a patient is crucial in managing chronic myeloid leukemia (CML). This type of cancer affects the blood and bone marrow. It is a lifelong battle. The patient must take medicine every day. Doctors and patients need to be on the same page. They need to agree on the treatment plan. This is called concordance. When this happens, patient...
Bladder cancer can stick around and get worse if it’s not well-managed. So following treatment plans strictly is really important. Digital health literacy and general health literacy are trendy words for knowing how to use health information effectively. This was tested on a group of patients freshly diagnosed with non muscle invasive bladder cancer. Patients who kn...
Imagine you have two tough health issues: type 2 diabetes (T2D) and chronic kidney disease (CKD). Doctors are finding new ways to treat these conditions, especially with a special kind of pill called an SGLT2 inhibitor. These pills are getting lots of attention in Europe, Japan, and the US. The FOUNTAIN study (NCT05526157) looked at adults with both T2D and CKD who ...
You know how mental illnesses like schizophrenia and bipolar disorder can be tough? Well, add to that the challenge of substance use. It's more common among these folks in southwestern Uganda. We checked out 385 patients from June to August 2022. We asked about their alcohol and cannabis use, support system, spiritual beliefs, following their treatment plan, and some...